Kenneth Michael Reali - Mar 14, 2022 Form 4/A - Amendment Insider Report for Bioventus Inc. (BVS)

Role
Fmr. CEO and Director, Director
Signature
/s/Anthony D'Adamio, Attorney-in-Fact
Stock symbol
BVS
Transactions as of
Mar 14, 2022
Transactions value $
$0
Form type
4/A - Amendment
Date filed
4/21/2023, 05:19 PM
Date Of Original Report
Mar 16, 2023
Previous filing
Sep 10, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BVS Stock Option (Right to Buy) Award $0 +466K $0.00 466K Mar 14, 2022 Class A Common Stock 466K $1.16 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options shall vest in four approximately equal installments on each of the first four anniversaries of March 14, 2022, in each case subject to the Reporting Person continuing in service through the applicable vesting date.

Remarks:

This Form 4 amendment is being filed to report the acquisition of stock options that were inadvertently omitted from the original filing.